Distinct Patterns of Brain Atrophy in Amnestic Mild Cognitive Impairment and Motoric Cognitive Risk Syndromes
- PMID: 39102797
- PMCID: PMC11794591
- DOI: 10.1159/000540512
Distinct Patterns of Brain Atrophy in Amnestic Mild Cognitive Impairment and Motoric Cognitive Risk Syndromes
Abstract
Introduction: Motoric cognitive risk (MCR) and amnestic mild cognitive impairment (aMCI) syndromes are each reliable predictors of incident Alzheimer's disease (AD), but MCR may be a stronger predictor of vascular dementia than AD. This study contrasted cortical and hippocampal atrophy patterns in MCR and aMCI.
Methods: Cross-sectional data from 733 older adults without dementia or disability (M age = 73.6; 45% women) in the multicountry MCR consortium were examined. MCR was defined as presence of slow gait and cognitive concerns. Amnestic MCI was defined as poor episodic memory performance and cognitive concerns. Cortical thickness and hippocampal volumes were quantified from structural MRIs. Multivariate and univariate general linear models were used to examine associations between cortical thickness and hippocampal volume in MCR and aMCI, adjusting for age, sex, education, total intracranial volume, white matter lesions, and study site.
Results: The prevalence of MCR and aMCI was 7.64% and 12.96%, respectively. MCR was associated with widespread cortical atrophy, including prefrontal, insular, cingulate, motor, parietal, and temporal atrophy. aMCI was associated with hippocampal atrophy.
Conclusion: Distinct patterns of atrophy were associated with MCR and aMCI. A distributed pattern of cortical atrophy - that is more consistent with VaD or mixed dementia- was observed in MCR. A more restricted pattern of atrophy - that is more consistent with AD - was observed in aMCI. The biological underpinnings of MCR and aMCI likely differ and may require tailored interventions.
Introduction: Motoric cognitive risk (MCR) and amnestic mild cognitive impairment (aMCI) syndromes are each reliable predictors of incident Alzheimer's disease (AD), but MCR may be a stronger predictor of vascular dementia than AD. This study contrasted cortical and hippocampal atrophy patterns in MCR and aMCI.
Methods: Cross-sectional data from 733 older adults without dementia or disability (M age = 73.6; 45% women) in the multicountry MCR consortium were examined. MCR was defined as presence of slow gait and cognitive concerns. Amnestic MCI was defined as poor episodic memory performance and cognitive concerns. Cortical thickness and hippocampal volumes were quantified from structural MRIs. Multivariate and univariate general linear models were used to examine associations between cortical thickness and hippocampal volume in MCR and aMCI, adjusting for age, sex, education, total intracranial volume, white matter lesions, and study site.
Results: The prevalence of MCR and aMCI was 7.64% and 12.96%, respectively. MCR was associated with widespread cortical atrophy, including prefrontal, insular, cingulate, motor, parietal, and temporal atrophy. aMCI was associated with hippocampal atrophy.
Conclusion: Distinct patterns of atrophy were associated with MCR and aMCI. A distributed pattern of cortical atrophy - that is more consistent with VaD or mixed dementia- was observed in MCR. A more restricted pattern of atrophy - that is more consistent with AD - was observed in aMCI. The biological underpinnings of MCR and aMCI likely differ and may require tailored interventions.
Keywords: Amnestic mild cognitive impairment; Cortical thickness; Hippocampal volume; Motoric cognitive risk.
© 2024 S. Karger AG, Basel.
Conflict of interest statement
Richard B. Lipton has received research support from the National Institutes of Health (NIH), the FDA, and the National Headache Foundation. He serves as a consultant, advisory board member, or has received honoraria or research support from AbbVie/Allergan, Amgen, Axon, Biohaven, Dr. Reddy’s Laboratories (Promius), electroCore, Eli Lilly and Company, GlaxoSmithKline, Lilly, Lundbeck, Merck, Novartis, Pfizer, Teva, Vector, and Vedanta Research. He receives royalties from Wolff’s Headache, 8th edition (Oxford University Press, 2009) and Informa. He holds stock/options in Axon, Biohaven, Cooltech, and Manistee. Helena M. Blumen serves as a consultant for Neural+.
Similar articles
-
Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.Brain Topogr. 2019 Jan;32(1):142-160. doi: 10.1007/s10548-018-0675-2. Epub 2018 Sep 11. Brain Topogr. 2019. PMID: 30206799
-
Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.Psychogeriatrics. 2016 Nov;16(6):355-361. doi: 10.1111/psyg.12176. Epub 2016 Jan 12. Psychogeriatrics. 2016. PMID: 26756596
-
Cortical Thickness, Volume, and Surface Area in the Motoric Cognitive Risk Syndrome.J Alzheimers Dis. 2021;81(2):651-665. doi: 10.3233/JAD-201576. J Alzheimers Dis. 2021. PMID: 33867359 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Procedural Learning in Individuals with Amnestic Mild Cognitive Impairment and Alzheimer's Dementia: a Systematic Review and Meta-analysis.Neuropsychol Rev. 2021 Mar;31(1):103-114. doi: 10.1007/s11065-020-09449-1. Epub 2020 Sep 8. Neuropsychol Rev. 2021. PMID: 32897482 Free PMC article.
Cited by
-
Motoric cognitive risk syndrome: A review of fall risk assessment and management strategies.World J Psychiatry. 2025 Apr 19;15(4):101800. doi: 10.5498/wjp.v15.i4.101800. eCollection 2025 Apr 19. World J Psychiatry. 2025. PMID: 40309596 Free PMC article. Review.
References
-
- Alzheimer’s disease facts and figures . Alzheimers Dement, 2021;17(3):327–406. - PubMed
-
- Simon SS, Yokomizo JE, Bottino CM. Cognitive intervention in amnestic Mild Cognitive Impairment: a systematic review. Neurosci Biobehav Rev. 2012;36(4):1163–78. - PubMed
-
- Huang X, Zhao X, Cai Y, Wan Q. The cerebral changes induced by exercise interventions in people with mild cognitive impairment and Alzheimer's disease: a systematic review. Arch Gerontol Geriatr. 2022;98:104547. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical